Integrated in silico analysis of LRP2 mutations to immunotherapy efficacy in pan-cancer cohort
Abstract Purpose Immunotherapy has emerged as a novel therapy, while many patients are refractory. Although, several biomarkers have been identified as predictive biomarkers for immunotherapy, such as tumor specific genes, PD-1/PD-L1, tumor mutation burn (TMB), and microsatellite instability (MSI),...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer
2022-07-01
|
| Series: | Discover Oncology |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1007/s12672-022-00528-8 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|